NanoBio adds 12 people in two years, looks to hire more

NanoBio has been growing at a rapid clip in the last two years, taking on ex-Pfizer employees and getting ready to license its products.

Excerpt:

What does $30 million buy a start-up these days? If it's NanoBio it’s a dozen new employees (including seven Pfizer refugees) and a couple of products very close to commercialization.

The Ann Arbor-based firm received $30 million in private equity from Perseus in 2006. That allowed the spin-off from the University of Michigan's Center for Biological Nanotechnology to expand its staff to 20 employees and three interns.

"We pretty much doubled in size right away," says John Coffey, vice president of business development for NanoBio.

Read the rest of the story here.
Enjoy this story? Sign up for free solutions-based reporting in your inbox each week.

Related Company

  • NanoBio
    2311 Green Road, Suite A
    Ann Arbor, MI 48105 Website
    NanoBio Corporation is a biopharmaceutical company founded by U-M faculty and focused on developing and commercializing anti-infective products and vaccines. With millions in investment and a half dozen products in the pipeline, they are an Ann Arbor ...